Clinical trial
Primary Thrombocythaemia 1 Trial
NCT00175838 · University of Cambridge, Other · Completed
Key facts
| NCT number | NCT00175838 |
|---|---|
| Title | Primary Thrombocythaemia 1 Trial |
| Official title | A Randomised Trial to Compare Aspirin vs Hydroxyurea/Aspirin in 'Intermediate Risk' Primary Thrombocythaemia and Aspirin Only With Observation in 'Low Risk'Primary Thrombocythaemia |
| Acronym | PT-1 |
| Lead sponsor | University of Cambridge, Other |
| Collaborators | Cambridge University Hospitals NHS Foundation Trust Institute of Cancer Research, United Kingdom |
| Status | Completed |
| Study type | Interventional |
| Conditions | Thrombocythemia, Myeloproliferative Disorder |
| Intervention type | Drug |
| Interventions | Hydroxyurea, Aspirin |
| Enrollment | 1,398 |
| Start date | Jul 1, 1997 |
| Primary completion | Nov 1, 2016 |
| Completion | Nov 1, 2016 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 18, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: